On Wednesday 24th February Factor 50 attended the opening of the Cellular Therapeutics Unit at the Core Technology Facility in Manchester. This is another big step forward in the work the Melanoma team are doing, enabling them to process cells used in the immunotherapy trial treatment more readily in the quantities needed.
Hopefully this fantastic facility will aid the teams quest to begin clinical trials on patients during 2010.
